We use cookies to improve your experience on this website. Read More Close

` John Buckley

Mr. John Buckley

Consultant Urologist

Hospital

Tralee

Department

Urology,Operating Theatre

Specialties

Biography

Mr. Buckley’s first introduction to Urological surgery was in Boston in the University Medical Centre where he was exposed to Dr. R. Krane's Unit. He also assisted at vascular access procedures and renal transplantation. Mr. Buckley has been a full time Urological Surgeon since 1987. He

read more

Additional Information

Medical Societies

President, Medical Students Representative Council           1978 - 1979

Fellow, Royal College of Surgeons of Ireland                       1984 - Present

Member, Scottish Urological Oncology Group                     1989 - Present

Member, British Associations Urological Surgeons

Member, Junior Advisory Committee to Glasgow Royal     1990 - Present

College of Surgeons and Physicians                                     1990 - 1993

Member, West of Scotland Urology Group                           1990 - Present

Corresponding Member American Association of Urology  1991 Present

Education

Education and Experience           

1973 - 1979          Medical School, University College, Cork

1968 - 1973          Collaiste an Spiorad Naomh, Cork

1962 - 1968          National School, Ballinora, Cork

 

Qualifications

Medical Degree  - MB BCh BAO June 1979 U.C.C

BSc Hons. Physiology - BSc (Hon.) (Physiol.) June 1981 U.C.C

Fellowship - FRCSI June 1984

Research Fellowship - July 1984 - May 1986

Higher Surgical Degree - M.Ch. U.C.C. June 1989

Specialist Training Fellowship - FRCS (Urol.) November 1991 London

Full Accreditation in Urology - C.H.S.TG (Urol.) June 1992 (RCSI)

Specialist Training European Board Fellowship - Board of Urology, July 1992

 

Distinctions

1974       Pre-medical, 1st Hons. Chemistry and Biology

1975       1st Medical, 2nd Hons. Biochemistry and Physiology

1976       2nd Medical, 2nd Hons. Anatomy

1977       3rd Medical, 2nd Hons. Pathology

1978       4th Medical, 2nd Hons. Forensic Medicine and Therapeutics

1979       Final Medicine, 2nd Hons. Surgery and Paediatrics, NIB BCh BOA

1981       BSc Hons. Physiology, 2nd Class Grade 1, University College, Cork Renal Physiology.

1984       RCSI Fellow of the Royal College of Surgeons in Ireland.

1989       MCh Thesis, Cork

1991       FRCS (Urol.) Specialist Fellowship Urological Surgery (London).

1992       C.H.S.T (Urol.) Accreditation, Higher Surgical Training, Urology June, 1992

1992       FEB (Urol.) Specialist Fellowship European Board of Urology, November, 1992

 

Training Courses Attended

-Stones and ESWL - Edinburgh, August, 1989

-Paediatric Urology - Toronto, May, 1991

-Spinal Injuries Course - Lodge Moor, Sheffield, October, 1992

-Laparoscopic Urology - Dublin, November, 1992

-Laser Prostatectomy - London, September, 1992

-Percutaneous and Endoscopic Stone Surgery - Amsterdam, June, 1990

-Reconstructive Urology Toronto, May, 1991

-Impotence/Sexual Dysfunction, Diagnosis and Management - Toronto, May 1991

-Geriatric Voiding Dysfunction - Toronto, May 1991

-Management of Stress Urinary Incontinence - Washington, May 1992

-Paediatric Urology - Washington, May 1992

-Sacral Anterior Root Simulators - Halifax, September, 1992

-Urodynamics and Pressure-How Analysis - Halifax, September, 1992

-Laparoscopic Urology - Dearbourn, Michigan, September, 1992

 

Research, Awards & Grants 

-National Institute of Health (NIH) Research Fellow, Boston University Medical Centre and Harvard Medical School (Deaconess Hospital).

-Co-investigator, Grant H-G 121796.

-"Mechanism of failure of Prosthetic Grafts" 1986

-NIH General Purpose Grant. Naval Blood Research Laboratory at Boston University Chief Investigator."The influence  of non-steroidal inflammatory agents on wound healing and wound contracture". 1986.

-Department of Home and Health, Royal Infirmary, Edinburgh.

-Chief Investigator, Principal Investigator."Urodynamic assessment of bladder neck dyssynergia in the young male".  1989

-Abbott Medical, Royal Infirmary Edinburgh, Co-investigator. "Terazocin in placebo the treatment controlled of benign  prostatic hyperplasia. A multicentre placebo controlled trial". 1989-1990

-Bioplasty Incorporated, Western & Royal Infirmaries and Royal Hospital for Sick Children, Glasgow. Chief  Investigator. "Bulking techniques. Injcctable silicon marcoparticles (polydimethylsiloxane). A new material to treat  stress incontinence and vesicoureteric". 1991-1993

-Ethicon, Royal Infirmary, Glasgow. Co-investigator. "The assessment of Polydioxanone (PDS) Vicryl mesh in the  urinary tract, in the rabbit modeP. 1992-1993.

-Caledonia Medical. Principal investigator. Glasgow & Cork University Hospital UCC lab.

-"Assessment of an endoscopically implantable artificial sphincter for stress incontinence". 1992-1993

-Brocades Pharma & Yamanouchi, Victoria Infirmary, Glasgow. Principal Investigator "A prospective, double blind  multicentre study to compare the efficacy and safety of Tamsulosin 0.4mg/day (a prostatic sclective alpha A blocker)  and Alfuzocin 2.5mg tid in patients with outlet obstruction secondary to benign prostatic hyperplasia. 1992-1993.

-Brocades Pharma & Yamanouchi, Victoria Infirmary, Glasgow. Principal Investigator. "A prospective double blind  multicentre, long-term study to assess the safety and efficacy of Tamsulosin 0.4mg/day in patients with outlet  obstruction secondary to benign prostatic hyperplasia. 1992-1993

-Bard. Royal Infirmary, Glasgow. Principal Investigator. "A randomised comparison of laser prostatectomy with  transurethral resection of the prostate in the treatment of benign prostatic hyperplasia. 1992-1993.

-Convatec, Bristol Myers Squibb. Cork University Hospital College Lab.

-Guy's & St. Thomas' Hospital Trust. Principal Investigator."The assessment of injectable hydroxyapatite as a bulking  material in the rabbit bladder. A potential new material to treat incontinence and vesicoureteric reflux". 1993 - Present.

-Pfizer. Cork University Hospital University College Lab. Principal Investigator. "A multicentre double blind study of a  new MS muscurinic receptor antagonist in patients with detrusor instability detrusor hyper-reflexia and urge  incontinence". 1994-1995

-Pfizer. Cork University Hospital University College lab. Principal  Investigator. “A multicentre double blind study of  40 weeks long term continuation of the M3 muscurine receptor antagonist in patients with detrusor instability, detrusor  hyperreflexia and urge incontinence 1994-1995

-Pharmacia. Cork University Hospital University College Lab. Principal Investigator. "A multicentre double blind  study to compare the efficacy of intravesical Oxybutynin with placebo in the relief of urgency and urge incontinence in  patients with detrusor instability or hyperreflexia on clean intermittent sclf catheterisation. 1994-1995

-Pharmacia. Cork University Hospital University College Lab. Principal Investigator. "A multicentre double blind  study to compare the efficacy of Oxybutynin tablets (5mg bd) in patients with dctrusor instability or hypcreflexia.  1994-1995

-The Irish Immunology Renal Cell Carcinoma Study, Cork University Hospital. Co-investigator.

-"An open multicentre study of immuno therapy in metastatic renal C) cell carcinoma" 1993-1995.

-Zeneca. Guy's & St. Thomas' Hospital Trust. Principal Investigator. "A randomised, double blind, parallel group trial    comparing Casodex 150mg with placebo in patients with non-metastatic prostate cancer" 1996 - Present.

-Bard. Guy's & St. Thomas' Hospital Trust. Principal Investigator. "The use of a temporary prostatic stent for the relief    of postoperative voiding dysfunction following laser ablation of the prostate: A randomiscd study" 1996 Present

-Bioniche. Guy's & St. Thomas' Hospital Trust. Principal Investigator "Treatment of refractory interstitial cystitis with     intravesical Hyaluronic acid (CystistatTM), a prospective study. 1996 - Present.

- Bioniche. Guy's & St. Thomas' Hospital Trust. Principal Investigator. "A clinical study to evaluate RegressinTM           (Mycobacterial cell wall extract) in the treatment of carcinoma in-situ of the human bladder. 1996 Present

 

 

Back to top

    Follow us:

    Visited Pages

    Appointment Request